Home | | Anesthesiology | Adrenergic Antagonists: Nebivolol

Chapter: Clinical Anesthesiology: Clinical Pharmacology: Adrenergic Agonists & Antagonists

Adrenergic Antagonists: Nebivolol

Nebivolol is a newer generation β-blocker with high affinity for β1-receptors.

NEBIVOLOL

Clinical Considerations

Nebivolol is a newer generation β-blocker with high affinity for β1-receptors. The drug is unique in its ability to cause direct vasodilation via its stimulatory effect on endothelial nitric oxide synthase. It is pres-ently available only in oral formulation; the recom-mended dose is 5–40 mg daily.

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Clinical Anesthesiology: Clinical Pharmacology: Adrenergic Agonists & Antagonists : Adrenergic Antagonists: Nebivolol |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.